27-30 April 2026
Vienna Congress & Convention CenterVienna, AustriaKey Sessions
Thomas Van Cangh
The European Biotech Act: What’s in it for the European Biotech sector?
European Commission
Daniela Ottini
Reimagining the Future of Biopharma Manufacturing & Supply: The Sanofi Modulus Example and Beyond
Sanofi
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Main Conference Day 1 (28th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Main Conference Day 1 (28th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)
search
Streams
Clear
Showing 1 of 1 Streams
Cell Line Development & Engineering
08:55 - 09:00
Chairperson's Opening Remarks
09:00 - 09:30
Beyond Random: Targeted Integration vs. Transposon Systems for High-Titre Stability
- Lasse Ebdrup Pedersen - Associate Professor, The Technical University of Denmark
09:30 - 10:00
CRISPR in Action: Multi-Gene Editing for Next-Generation Host Cells
Strategies for multiplexed CRISPR editing beyond ‘simple’ single-gene knockouts
Approaches to enable simultaneous modification of multiple genes and engineer complex traits
The journey of systematic creation of a ‘designer’ CHO host
Navigating the technical challenges when using CRISPR technology:
Off-target effects
Delivery efficiency, etc.
Showing 1 of 1 Streams
Cell Line Development & Engineering
11:15 - 11:45
Secretome Engineering: Targeted HCP Knockout to De-Bottleneck Downstream
- A Representative from Novartis - (Pending Final Confirmation), Novartis
11:45 - 12:15
Glycoengineering for Impact: Selecting Optimal Therapeutic Candidates Using geCHO Technology
- Bjørn Voldborg - Director CHO Cell Line Development, The Novo Nordisk Foundation Center for Biosustainability
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear